AB-2004 in Treatment of Irritability Associated With Autism Spectrum Disorder (ASD)
Summary
- Eligibility
- for people ages 13-17 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Axial Therapeutics, Inc.
- ID
- NCT04895215
- Phase
- Phase 2 Autism Research Study
- Study Type
- Interventional
- Participants
- Expecting 140 study participants
- Last Updated